PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR PNEUMOCYSTIS

NIH RePORTER · NIH · N01 · $1,185,838 · view on reporter.nih.gov ↗

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

Key facts

NIH application ID: 10134161
Project number: 272201500007I-P00005-27200007-1
Recipient: ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
Principal Investigator: KRISTOPHER PAOLINO
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $1,185,838
Award type: —
Project period: 2018-03-30 → 2023-01-25